Shanghai INT Medical Instruments Co., Ltd.

SEHK:1501 Stock Report

Market Cap: HK$4.8b

Shanghai INT Medical Instruments Management

Management criteria checks 2/4

Shanghai INT Medical Instruments' CEO is Dongke Liang, appointed in Jun 2010, has a tenure of 14.5 years. total yearly compensation is CN¥6.14M, comprised of 21.5% salary and 78.5% bonuses, including company stock and options. directly owns 6.84% of the company’s shares, worth HK$328.77M. The average tenure of the management team and the board of directors is 5.6 years and 4.3 years respectively.

Key information

Dongke Liang

Chief executive officer

CN¥6.1m

Total compensation

CEO salary percentage21.5%
CEO tenure14.5yrs
CEO ownership6.8%
Management average tenure5.6yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Jul 14
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

May 17
Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Nov 26
Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Aug 16
Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Apr 24
Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

Apr 05
Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Mar 15
What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Jan 28
Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Dec 28
Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

Dec 02
Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

CEO Compensation Analysis

How has Dongke Liang's remuneration changed compared to Shanghai INT Medical Instruments's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥167m

Mar 31 2024n/an/a

CN¥160m

Dec 31 2023CN¥6mCN¥1m

CN¥152m

Sep 30 2023n/an/a

CN¥155m

Jun 30 2023n/an/a

CN¥159m

Mar 31 2023n/an/a

CN¥144m

Dec 31 2022CN¥4mCN¥1m

CN¥130m

Sep 30 2022n/an/a

CN¥137m

Jun 30 2022n/an/a

CN¥143m

Mar 31 2022n/an/a

CN¥143m

Dec 31 2021CN¥1mCN¥625k

CN¥143m

Sep 30 2021n/an/a

CN¥124m

Jun 30 2021n/an/a

CN¥105m

Mar 31 2021n/an/a

CN¥113m

Dec 31 2020CN¥921kCN¥891k

CN¥121m

Compensation vs Market: Dongke's total compensation ($USD841.27K) is above average for companies of similar size in the Hong Kong market ($USD479.24K).

Compensation vs Earnings: Dongke's compensation has increased by more than 20% in the past year.

CEO

Dongke Liang (46 yo)

14.5yrs

Tenure

CN¥6,140,000

Compensation

Dr. Dongke Liang has been Executive Chairman of the Board at Shanghai INT Medical Instruments Co., Ltd. (formerly known as Shanghai Kindly Medical Instruments Co., Ltd.) since April 26, 2016 and also has b...

Leadership Team

NamePositionTenureCompensationOwnership
Dongke Liang
Executive Chairman of the Board & GM14.5yrsCN¥6.14m6.84%
HK$ 328.8m
Sen Lin
Executive Director2.6yrsCN¥1.01m4.06%
HK$ 195.0m
Yuan Song
Deputy GM6.3yrsCN¥1.03mno data
Zixiong Wu
Finance Controller2.3yrsno datano data
Shui Bing Leung
Joint Company Secretary5.6yrsno datano data

5.6yrs

Average Tenure

46yo

Average Age

Experienced Management: 1501's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dongke Liang
Executive Chairman of the Board & GM18.5yrsCN¥6.14m6.84%
HK$ 328.8m
Sen Lin
Executive Director2.6yrsCN¥1.01m4.06%
HK$ 195.0m
Yuan Song
Deputy GM2.6yrsCN¥1.03mno data
Hung Kwan Hui
Independent Non-Executive Director6yrsCN¥120.00kno data
Huifang Ma
Chairperson of the Board of Supervisors2.6yrsno datano data
Weixin Zhang
Non-Executive Director6yrsno datano data
Hongqin Chen
Non-Executive Director6yrsno datano data
Xigao Jian
Independent Non-Executive Director6yrsCN¥120.00kno data
Jie Chen
Supervisor7.8yrsno datano data
Ruiqin Wang
Non-Executive Director2.6yrsCN¥799.00k4.06%
HK$ 195.0m
Congli Xu
Independent Non-Executive Director2.6yrsCN¥120.00kno data
Xiaoru Shen
Shareholder Representative Supervisor2.6yrsno datano data

4.3yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 1501's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 12:10
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai INT Medical Instruments Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited
Yu WuCMB International Securities Limited
Xin Qiu LinGuoyuan Securities (HK) Ltd